TGA Approval

RETEVMO selpercatinib 40 mg immediate release capsules (391331)

ARTG ID

391331

ARTG Name

RETEVMO selpercatinib 40 mg immediate release capsules

Sponsor

Eli Lilly Australia Pty Ltd

ARTG Date

July 3, 2023

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered - Prescription

Sponsor Information

Sponsor Name

Sponsor Item Name

ELI LILLY AUSTRALIA PTY LTD

https://medical-cdn.nocode.com/drug_tga/be6f06d5e0c4d602a59ed0dd7476422c.pdf

https://medical-cdn.nocode.com/drug_tga/b7e7123b692634c4b3971468717cef37.pdf

Ingredient Name

selpercatinib

Empowering clinical research with data-driven insights and AI-powered tools.

RETEVMO selpercatinib 40 mg immediate release capsules (391331) - TGA 批准文号 | MedPath